However, this intervention may have the following complications: by inhibiting the activity of TNF, anti-TNF drugs may weaken the ability of the immune system to monitor and eliminate tumour cells, thereby increasing the risk of tumourigenesis [8]. This evidence concerns the gene TNF and neoplasm.